Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2H-Indazole, 2-[(3-fluorophenyl)methyl]-5-nitro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

884874-01-5

Post Buying Request

884874-01-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

884874-01-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 884874-01-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,4,8,7 and 4 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 884874-01:
(8*8)+(7*8)+(6*4)+(5*8)+(4*7)+(3*4)+(2*0)+(1*1)=225
225 % 10 = 5
So 884874-01-5 is a valid CAS Registry Number.

884874-01-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(3-fluorophenyl)methyl]-5-nitro-indazole

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:884874-01-5 SDS

884874-01-5Relevant articles and documents

Hetero-aromatic compound and its use in medicine

-

Paragraph 1521; 1524-1527, (2019/07/04)

The invention provides a hetero-aromatic compound or a stereisomer, geometric isomer, tautomer, despinner, nitrogen oxide, hydrate, solvate, metabolite, metabolism precursor and pharmaceutically acceptable salt or prodrug thereof, which is used for treating proliferative diseases. The invention also discloses a pharmaceutical composition containing the compound and an application of the compound or pharmaceutical composition thereof in preparation of a medicine for treating proliferative diseases.

Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors

-

Page/Page column 12-13, (2008/06/13)

Cyanoguanidine quinazoline and cyanoamidine quinazolamine derivatives that are useful in the treatment of hyperproliferative diseases are disclosed. Methods of treating hyperproliferative diseases in mammals are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 884874-01-5